SLC7A11 and glioma: In gliomas and/or other neuronal cancers, inhibition of the cystine-glutamate transporter, xCT, reduces the invasiveness of glioma xenografts, probably due to a decrease in glutamate release to the extracellular space resulting in reduced excitotoxic death of neurons via excess glutamate14.